Sabejon, Evelyn N.
HRN: 01-47-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/03/2026
03/10/2026
IV
300mg
Q6H
Infected Wound, Left Foot
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: